Physician profile
David Way
NPI 1477555191
$1,039.48
in general payments reported to CMS, 2019-2025
9 companies · $154 in 2025
The $154 reported for 2025 was more than what a typical provider received nationally.
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $133 · 2021: $116 · 2022: $113 · 2023: $131 · 2024: $392 · 2025: $154.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $677.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $677.25 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $285.95 | 2024-2025 | Tavneos, Repatha |
| Regeneron Healthcare Solutions, INC. | $131.40 | 2023 | |
| Medtronic, INC. | $130.58 | 2024 | Kyphon Express II Kyphopak Tray |
| Alexion Pharmaceuticals, INC. | $116.24 | 2021 | |
| Abbott Laboratories | $112.75 | 2022 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $111.42 | 2024 | |
| Abbvie INC. | $109.95 | 2019 | |
| Shire North American Group INC | $23.29 | 2019 | |
| Tarsus Pharmaceuticals, INC. | $17.90 | 2025 | Xdemvy |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw David Way listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.